3
Announcements
Trials
Browse
Landscape
Status
Completed
5
Withdrawn
1
Not yet recruiting
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
6
Leukemia, Myeloid, Acute
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
3
Sarcoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Lung Neoplasms
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Melanoma
2
Lymphoma
2
Leukemia, Biphenotypic, Acute
2
Colonic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Burkitt Lymphoma
2
Uterine Cervical Dysplasia
1
Tongue Neoplasms
1
Thrombocytosis
1
Thrombocytopenia
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Pruritus
1
Interventions
Oxaliplatin
2
Fluorouracil
2
tremelimumab
1
pembrolizumab
1
monalizumab
1
epacadostat
1
durvalumab
1
Surgical Procedures, Operative
1
Nivolumab
1
Metabolic Networks and Pathways
1
Leucovorin
1
Immune Checkpoint Inhibitors
1
Fecal Microbiota Transplantation
1
Biopsy
1
AMG 337
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Adenocarcinoma Of Esophagus
×
Biopsy
×
Clear all
NCT06702384
2025-02-06
MAGnET
Royal Marsden NHS Foundation Trust
Withdrawn